|
WO2018094148A1
(en)
|
2016-11-18 |
2018-05-24 |
Arcus Biosciences, Inc. |
Inhibitors of cd73-mediated immunosuppression
|
|
CN110382544B
(zh)
|
2017-03-16 |
2023-12-22 |
先天制药公司 |
用于治疗癌症的组合物和方法
|
|
US11129841B2
(en)
|
2017-05-10 |
2021-09-28 |
Oric Pharmaceuticals, Inc. |
CD73 inhibitors
|
|
SG11202002192QA
(en)
|
2017-10-06 |
2020-04-29 |
Innate Pharma |
Restoration of t cell activity via the cd39/cd73 axis
|
|
US11377469B2
(en)
|
2017-11-03 |
2022-07-05 |
Oric Pharmaceuticals, Inc. |
CD73 inhibitors
|
|
CN112004541A
(zh)
|
2018-03-09 |
2020-11-27 |
艾库斯生物科学有限公司 |
肠道外给药的免疫增强药物
|
|
AU2019261976B2
(en)
|
2018-04-30 |
2025-01-23 |
Oric Pharmaceuticals, Inc. |
CD73 inhibitors
|
|
WO2019232319A1
(en)
|
2018-05-31 |
2019-12-05 |
Peloton Therapeutics, Inc. |
Compositions and methods for inhibiting cd73
|
|
AU2019289646B2
(en)
|
2018-06-18 |
2025-10-23 |
Innate Pharma |
Compositions and methods for treating cancer
|
|
WO2020047082A1
(en)
*
|
2018-08-28 |
2020-03-05 |
Eternity Bioscience Inc. |
Cd73 inhibitors and therapeutic uses thereof
|
|
US11530234B2
(en)
|
2018-09-11 |
2022-12-20 |
Risen (Suzhou) Pharma Tech Co., Ltd. |
CD73 inhibitors and pharmaceutical uses thereof
|
|
CN110885352B
(zh)
*
|
2018-09-11 |
2023-02-24 |
润佳（苏州）医药科技有限公司 |
Cd73抑制剂及其药学应用
|
|
US10881681B2
(en)
|
2018-09-11 |
2021-01-05 |
Risen (Suzhou) Pharma Tech Co., Ltd. |
CD73 inhibitors and pharmaceutical uses thereof
|
|
KR20210114963A
(ko)
|
2019-01-11 |
2021-09-24 |
오메로스 코포레이션 |
암을 치료하기 위한 방법 및 조성물
|
|
WO2020151707A1
(zh)
*
|
2019-01-22 |
2020-07-30 |
江苏恒瑞医药股份有限公司 |
一种新型的小分子cd73抑制剂、其制备方法及其在医药上的应用
|
|
KR20210137162A
(ko)
*
|
2019-03-12 |
2021-11-17 |
아르커스 바이오사이언시즈 인코포레이티드 |
종양유전자-유발 암의 치료
|
|
CN113874397A
(zh)
|
2019-03-29 |
2021-12-31 |
艾库斯生物科学有限公司 |
利用鉴定的腺苷指纹治疗癌症
|
|
PT4051688T
(pt)
|
2019-10-30 |
2025-06-30 |
Oric Pharmaceuticals Inc |
Inibidores de cd73
|
|
EP4121409A1
(en)
|
2020-03-19 |
2023-01-25 |
Arcus Biosciences, Inc. |
Tetralin and tetrahydroquinoline compounds as inhibitors of hif-2alpha
|
|
PE20231078A1
(es)
|
2020-06-02 |
2023-07-17 |
Arcus Biosciences Inc |
Anticuerpos anti-tigit
|
|
US20240226115A1
(en)
|
2021-05-21 |
2024-07-11 |
Arcus Biosciences, Inc. |
Axl inhibitor compounds
|
|
WO2022246177A1
(en)
|
2021-05-21 |
2022-11-24 |
Arcus Biosciences, Inc. |
Axl compounds
|
|
IL312348A
(en)
|
2021-10-29 |
2024-06-01 |
Arcus Biosciences Inc |
HIF-2ALPHA inhibitors and methods of using it
|
|
CA3256033A1
(en)
|
2022-04-13 |
2023-10-19 |
Arcus Biosciences, Inc. |
POLYTHERAPY FOR THE TREATMENT OF CANCERS EXPRESSING TOO MUCH-2
|
|
CA3256561A1
(en)
|
2022-05-02 |
2023-11-09 |
Arcus Biosciences, Inc. |
Anti-tigit antibodies and their uses
|
|
WO2023241699A1
(zh)
*
|
2022-06-17 |
2023-12-21 |
上海森辉医药有限公司 |
一种环戊基腺苷衍生物及其药物用途
|
|
EP4554680A1
(en)
|
2022-07-15 |
2025-05-21 |
Arcus Biosciences, Inc. |
Inhibitors of hpk1 and methods of use thereof
|
|
WO2024020034A1
(en)
|
2022-07-20 |
2024-01-25 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
EP4587001A1
(en)
|
2022-09-14 |
2025-07-23 |
Arcus Biosciences, Inc. |
Dispersions of etrumadenant
|
|
WO2024081385A1
(en)
|
2022-10-14 |
2024-04-18 |
Arcus Biosciences, Inc. |
Hpk1 inhibitors and methods of use thereof
|
|
WO2024233360A1
(en)
|
2023-05-05 |
2024-11-14 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
CN116298323B
(zh)
*
|
2023-05-16 |
2023-08-22 |
南京联笃生物科技有限公司 |
一种用于诊断狼疮性肾炎的生物标志物及应用
|
|
US20250011318A1
(en)
|
2023-05-25 |
2025-01-09 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
WO2025054339A1
(en)
|
2023-09-08 |
2025-03-13 |
Arcus Biosciences, Inc. |
Triazolopyridine compounds as inhibitors of kit
|
|
WO2025072330A1
(en)
|
2023-09-26 |
2025-04-03 |
Arcus Biosciences, Inc. |
Kit inhibitor compounds and methods of use thereof
|
|
WO2025076299A1
(en)
|
2023-10-06 |
2025-04-10 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
WO2025096979A1
(en)
|
2023-11-02 |
2025-05-08 |
Arcus Biosciences, Inc. |
Thiazole compounds as kit inhibitors and methods of use thereof
|
|
WO2025119278A1
(zh)
*
|
2023-12-07 |
2025-06-12 |
无锡和誉生物医药科技有限公司 |
一种cd73抑制剂药物组合物，其制备方法和应用
|
|
WO2025137640A1
(en)
|
2023-12-22 |
2025-06-26 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
WO2025193759A1
(en)
|
2024-03-12 |
2025-09-18 |
Gilead Sciences, Inc. |
Solid forms of an azolopyrimidine compound
|
|
WO2025233264A1
(en)
|
2024-05-07 |
2025-11-13 |
Innate Pharma |
Use of cd73 blocking agents in combination with anti-cd20 x cd3 t cell engagers
|
|
WO2026006759A1
(en)
|
2024-06-28 |
2026-01-02 |
Arcus Biosciences, Inc. |
Pharmaceutical compositions, dosage forms, and methods of making and using same
|